---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-25-000012"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:30:25.669240+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BeiGene expects positive operating income for FY 2025 under US GAAP at J.P. Morgan conference

## Summary
- Announced at 43rd Annual J.P. Morgan Healthcare Conference on Jan 13, 2025.
- Expects to achieve positive operating income for full year 2025 per US GAAP.
- Guidance does not assume any new material business development or unusual/non-recurring items.
- Replay available on BeiGene's investor website for 30 days.

## SEC filing metadata
- accession: 0001651308-25-000012
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000012/0001651308-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000012/bgne-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-25-000012
- JSON: https://secwatch.observer/filing/0001651308-25-000012.json
- Plain text: https://secwatch.observer/filing/0001651308-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.